scholarly journals PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA

2017 ◽  
Vol 35 ◽  
pp. 251-252 ◽  
Author(s):  
T. Witzig ◽  
L. Sokol ◽  
E. Jacobsen ◽  
R. Advani ◽  
R. Mondejar ◽  
...  
Keyword(s):  
T Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Open Label ◽  
Peripheral T Cell Lymphoma ◽  
Preliminary Results ◽  
Open Label Phase

A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e20044-e20044
Author(s):  
Simone M. Goldinger ◽  
Sharon Gobbi ◽  
Michelle Ding ◽  
Anna Lisa Frauchiger ◽  
Regina Fink-Puches ◽  
...  
Keyword(s):  
T Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase

Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 8033-8033 ◽  
Author(s):  
S. M. Horwitz ◽  
B. Coiffier ◽  
F. M. Foss ◽  
H. M. Prince ◽  
L. Sokol ◽  
...  
Keyword(s):  
T Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Peripheral T Cell Lymphoma
Sign in / Sign up

Export Citation Format

Share Document